alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
I 

113TH CONGRESS 

1ST SESSION H. R. 1047 

To extend the temporary suspension of duty on Disperse Orange 30. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 11, 2013 

Mr. WATT introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To extend the temporary suspension of duty on Disperse 

Orange 30. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DISPERSE ORANGE 30. 

4 (a) IN GENERAL.—Heading 9902.03.45 of the Har5 monized Tariff Schedule of the United States (relating to 

6 Disperse Orange 30) is amended by striking the date in 

7 the effective period column and inserting ‘‘12/31/2016’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to goods entered, or withdrawn from 


jbell on DSK7SPTVN1PROD with BILLS
2 

•HR 1047 IH

1 warehouse for consumption, on or after the 15th day after 

2 the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
[Federal Register Volume 87, Number 119 (Wednesday, June 22, 2022)]
[Notices]
[Page 37339]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-13302]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of General Medical 
Sciences Special Emphasis Panel; NIGMS Review of Centers of 
Biomedical Research Excellence (COBRE) Phase 1 Applications.
    Date: July 13-14, 2022.
    Time: 10:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of General Medical Sciences, Natcher 
Building, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Nina Sidorova, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Institute of General Medical 
Sciences, National Institutes of Health, 45 Center Drive, Room 
3An.22, Bethesda, MD 20892-6200, 301-594-3663, 
<a href="/cdn-cgi/l/email-protection#75061c111a071a0314351b1c1218065b1b1c1d5b121a03"><span class="__cf_email__" data-cfemail="54273d303b263b2235143a3d3339277a3a3d3c7a333b22">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.375, 
Minority Biomedical Research Support; 93.821, Cell Biology and 
Biophysics Research; 93.859, Pharmacology, Physiology, and 
Biological Chemistry Research; 93.862, Genetics and Developmental 
Biology Research; 93.88, Minority Access to Research Careers; 93.96, 
Special Minority Initiatives; 93.859, Biomedical Research and 
Research Training, National Institutes of Health, HHS)

    Dated: June 15, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-13302 Filed 6-21-22; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
RICHARD ABRAM

ALEXANDER

,

Appellant,

v.

S TATE OF FLORIDA

,

Appellee

. IN THE DISTRICT COURT OF APPEAL

FIRST DISTRICT, STATE OF FLORIDA

NOT FINAL UNTIL TIME EXPIRES TO

FILE MOTION FOR REHEARING AND

DISPOSITION THEREOF IF FILED

CASE NO. 1D 1 6

- 1 891

_____________________________/

Opinion filed September 1, 2017.

An appeal from an order of the Circuit Court for Duval County.

Mark J. Borello , Judge.

Andy Thomas, Public Defender, and David A. Henson , Assistant Public Defender,

Tallahassee , for Appella nt

.

Pamela Jo Bondi, Attorney General, and Sharon S. Traxler , Assistant Attorney

General, Tallahassee

, for Appellee.

PER CURIAM.

AFFIRMED.

KELSEY, WINOKUR, and WINSOR, J J

., CONCUR.
# Official Journal C 190A/18 M

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 190A |
| | |
| English edition | Information and Notices | Volume 6418 May 2021 |

ISSN 1977-091X

Official Journal

of the European Union

C 190A

English edition

Information and Notices

Volume 6418 May 2021

---

| Contents | page |
| --- | --- |
| | V   Announcements |
| | ADMINISTRATIVE PROCEDURES |
| | Council |
| 2021/C 190 A/01 | Notice of vacancy CONS/AD/169/21 | 1 |

Contents

page

V   Announcements

ADMINISTRATIVE PROCEDURES

Council

2021/C 190 A/01

Notice of vacancy CONS/AD/169/21

1

---

| EN | |
| --- | --- |

EN
MUSHKIN, INC., Petitioner v. ANZA TECHNOLOGY, INC.

No. 19-610

Supreme Court of the United States.

January 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Federal Circuit denied.
To the Shareholders and Board of Directors of
Salomon Brothers Variable Series Funds Inc

                                                            (2)


               Report of Independent Accountants


To the Shareholders and Board of Directors of
Salomon Brothers Variable Series Funds Inc


In planning and performing our audit of the financial
statements of Salomon Brothers Variable High Yield Bond Fund
(one of the portfolios constituting Salomon Brothers Variable
Series Funds Inc, hereafter referred to as the Fund) for the
year ended December 31, 2002, we considered its internal
control, including control activities for safeguarding
securities, in order to determine our auditing procedures for
the purpose of expressing our opinion on the financial
statements and to comply with the requirements of Form N-SAR,
not to provide assurance on internal control.

The management of the Fund is responsible for establishing and
maintaining internal control.  In fulfilling this
responsibility, estimates and judgments by management are
required to assess the expected benefits and related costs of
controls.  Generally, controls that are relevant to an audit
pertain to the entity's objective of preparing financial
statements for external purposes that are fairly presented in
conformity with generally accepted accounting principles.
Those controls include the safeguarding of assets against
unauthorized acquisition, use or disposition.

Because of inherent limitations in internal control, errors or
fraud may occur and not be detected.  Also, projection of any
evaluation of internal control to future periods is subject to
the risk that controls may become inadequate because of changes
in conditions or that the effectiveness of their design and
operation may deteriorate.

Our consideration of internal control would not necessarily
disclose all matters in internal control that might be material
weaknesses under standards established by the American
Institute of Certified Public Accountants.  A material weakness
is a condition in which the design or operation of one or more
of the internal control components does not reduce to a
relatively low level the risk that misstatements caused by
error or fraud in amounts that would be material in relation to
the financial statements being audited may occur and not be
detected within a timely period by employees in the normal
course of performing their assigned functions.  However, we
noted no matters involving internal control and its operation,
including controls for safeguarding securities, that we
consider to be material weaknesses as defined above as of
December 31, 2002.

This report is intended solely for the information and use of
management and the Board of Directors of the Fund and the
Securities and Exchange Commission and is not intended to be
and should not be used by anyone other than these specified
parties.




PricewaterhouseCoopers LLP

February 18, 2003
```
 
 
VIX FUTURES - CBOE FUTURES EXCHANGE                                  Code-1170E1
OPTION AND FUTURES COMBINED POSITIONS AS OF 07/15/14          |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  Long  | Short  |Spreads |  Long  | Short  |  Long  | Short  |  Long  | Short
--------------------------------------------------------------------------------
($1000 X INDEX)                                      OPEN INTEREST:      435,001
COMMITMENTS
 140,160  190,565  101,926  165,725  114,769  407,811  407,260   27,190   27,741

CHANGES FROM 07/08/14 (CHANGE IN OPEN INTEREST:    -22,196)
  -7,792  -28,214      651  -10,533   11,171  -17,674  -16,392   -4,522   -5,804

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADER
    32.2     43.8     23.4     38.1     26.4     93.7     93.6      6.3      6.4

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      217)
      68       87       82       41       41      161      169
```

----

Updated July 18, 2014
VIA EDGAR 
 
October 7, 1996
 
Securities and Exchange Commission 
Judiciary Plaza 
450 Fifth Street NW 
Washington, DC 
 
ATTN:		Office of Filings, Information and Consumer Services 
 
RE: 		Greenwich Street Municipal Fund Inc. 
		File No. 33-58610 
 
Gentlemen: 
 
Pursuant to Rule 497(j) under the Securities Act of 1933, as amended, 
please  accept this letter as certification that the prospectus and the 
statement of  additional information for the above-referenced Portfolio does 
not differ from  that contained in Post-Effective Amendment No. 1 
(the "Amendment") to the  Fund's Registration Statement on Form N-2.  
This Amendment was filed electronically on September 30, 1996. 
 
Any comments on this filing should be directed to me at 212-816-5770. 
 
Please return an electronic transmittal as evidence of your receipt of 
this  filing. 
 
 
						Very truly yours, 
 
 
						/s/Michael Kocur 
						Michael Kocur 
						Vice President and 
						Assistant General Counsel
Abdifatah Gaas QORANE, Petitioner v. William P. BARR, Attorney General

No. 19-385

Supreme Court of the United States.

January 13, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
Electronically Filed

Intermediate Court of Appeals

CAAP-17-0000660

11-OCT-2019

08:02 AM
Exhibit 32.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Sunset Financial Resources, Inc., (the Company) on Form 10-Q for the period ending September 30, 2005 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, George O. Deehan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:



(1) The Report fully complies with the requirements of
section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and



(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                       
|-----------------------
|/s/ George O. Deehan   
|George O. Deehan       
|Chief Executive Officer



November 14, 2005
Independent Auditors' Consent



To the Shareholders and Board of Directors of
Smith Barney World Funds, Inc.:
We consent to the incorporation by reference, with respect to the
portfolios listed below for the Smith Barney World Funds, Inc.
(the "Funds"), in the respective Prospectus and Statement of
Additional Information, of our report dated December 11, 2000, on
the statement of assets and liabilities as of October 31, 2000,
and the related statement of operations for the year then ended,
the statements of changes in net assets for each of the years in
the two-year period then ended and the financial highlights for
each of the years in the five-year period then ended.  These
financial statements and financial highlights and our report
thereon are included in the Annual Report of the Funds as filed on
Form N-30D.
We also consent to the references to our firm under the headings
"Financial Highlights" in the respective Prospectus and
"Independent Auditors" in the Statement of Additional Information.
Portfolios

Global Government Bond Portfolio
International All Cap Growth Portfolio
European Portfolio




KPMG LLP
New York, New York
February 26, 2001
Page
December 5, 2000

VIA EDGAR

Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street
Washington, D.C. 20549

Attn:	Office of Filings, Information and Consumer
Services

Re:	Smith Barney Investment Funds, Inc. (the
"Company")
	File Nos. 002-74288 and 811-3275

Gentlemen:

The 485APOS filing made on December 1, 2000,
Accession Number 91155-00-000697
 was made in error.  Please disregard the filing and
remove it from the EDGAR database.

Please return an electronic transmittal as evidence
of receipt of this filing.

Any questions regarding this filing should be
directed to the undersigned at (212) 783-7112.

Very truly yours,

/s/ Amy Bennett
Amy Bennett
Paralegal
Jeffrey F. EVERS, Petitioner v. Brian FOSTER, Warden.

No. 19-6392

Supreme Court of the United States.

December 9, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Seventh Circuit denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Commerce

###### Foreign-Trade Zones Board

          - [B-04-2022]

On February 14, 2022, AstraZeneca Pharmaceuticals, LP submitted a notification of proposed production activity to the FTZ Board for its facility within FTZ Subzone 177A, in Mount Vernon, Indiana.

                    The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the                     **Federal Register**                     inviting public comment (87 FR 10332-10333, February 24, 2022). On June 14, 2022, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.                

Dated: June 14, 2022.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2022-13065 Filed 6-16-22; 8:45 am]

BILLING CODE 3510-DS-P
# Official Journal C 166/2021

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 166 |
| | |
| English edition | Information and Notices | Volume 644 May 2021 |

ISSN 1977-091X

Official Journal

of the European Union

C 166

English edition

Information and Notices

Volume 644 May 2021

---

| Contents | page |
| --- | --- |
| | III   Preparatory acts |
| | COUNCIL |
| 2021/C 166/01 | Position (EU) No 12/2021 of the Council at first reading with a view to the adoption of a Regulation of the European Parliament and of the Council establishing the Citizens, Equality, Rights and Values Programme and repealing Regulation (EU) No 1381/2013 of the European Parliament and of the Council and Council Regulation (EU) No 390/2014Adopted by the Council on 19 April 2021 | 1 |
| 2021/C 166/02 | Statement of the Council’s reasons: Position (EU) No 12/2021 of the Council at first reading with a view to the adoption of a Regulation of the European Parliament and of the Council establishing the Citizens, Equality, Rights and Values Programme and repealing Regulation (EU) No 1381/2013 of the European Parliament and of the Council and Council Regulation (EU) No 390/2014 | 20 |

Contents

page

III   Preparatory acts

COUNCIL

2021/C 166/01

Position (EU) No 12/2021 of the Council at first reading with a view to the adoption of a Regulation of the European Parliament and of the Council establishing the Citizens, Equality, Rights and Values Programme and repealing Regulation (EU) No 1381/2013 of the European Parliament and of the Council and Council Regulation (EU) No 390/2014Adopted by the Council on 19 April 2021

1

2021/C 166/02

Statement of the Council’s reasons: Position (EU) No 12/2021 of the Council at first reading with a view to the adoption of a Regulation of the European Parliament and of the Council establishing the Citizens, Equality, Rights and Values Programme and repealing Regulation (EU) No 1381/2013 of the European Parliament and of the Council and Council Regulation (EU) No 390/2014

20

---

| EN | |
| --- | --- |

EN
I 

113TH CONGRESS 

1ST SESSION H. R. 1054 

To suspend temporarily the duty on Disperse Yellow 114. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 11, 2013 

Mr. WATT introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To suspend temporarily the duty on Disperse Yellow 114. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. DISPERSE YELLOW 114. 

4 (a) IN GENERAL.—Subchapter II of chapter 99 of 

5 the Harmonized Tariff Schedule of the United States is 

6 amended by inserting in numerical sequence the following 

7 new heading: 

‘‘ 9902.01.00 Disperse Yellow 114 (CAS 

No. 59312–61–7) (provided for in subheading 

3204.11.50) ....................... Free No change No change On or before 

12/31/2016 ’’. 

8 (b) EFFECTIVE DATE.—The amendment made by 

9 subsection (a) applies to articles entered, or withdrawn 


jbell on DSK7SPTVN1PROD with BILLS
2 

•HR 1054 IH

1 from warehouse for consumption, on or after the 15th day 

2 after the date of the enactment of this Act. 

Æ 


jbell on DSK7SPTVN1PROD with BILLS
<TABLE> <S> <C>

<ARTICLE> 6
<CIK> 0000919557
<NAME> Smith Barney Large Cap Value Portfolio
<SERIES>
   <NUMBER>001
   <NAME>Travelers Series Fund Inc.

<S>                         <C>
<PERIOD-TYPE>              Year
<FISCAL-YEAR-END>                 Oct-31-2001
<PERIOD-END>                      Oct-31-2000
<INVESTMENTS-AT-COST>             474,798,573
<INVESTMENTS-AT-VALUE>            553,721,837
<RECEIVABLES>                         938,768
<ASSETS-OTHER>                            570
<OTHER-ITEMS-ASSETS>                        0
<TOTAL-ASSETS>                    554,661,175
<PAYABLE-FOR-SECURITIES>              845,828
<SENIOR-LONG-TERM-DEBT>                     0
<OTHER-ITEMS-LIABILITIES>             504,600
<TOTAL-LIABILITIES>                 1,350,428
<SENIOR-EQUITY>                             0
<PAID-IN-CAPITAL-COMMON>          447,326,744
<SHARES-COMMON-STOCK>              26,683,826
<SHARES-COMMON-PRIOR>              27,423,892
<ACCUMULATED-NII-CURRENT>           7,598,914
<OVERDISTRIBUTION-NII>                      0
<ACCUMULATED-NET-GAINS>            19,461,825
<OVERDISTRIBUTION-GAINS>                    0
<ACCUM-APPREC-OR-DEPREC>           78,923,264
<NET-ASSETS>                      553,310,747
<DIVIDEND-INCOME>                  10,720,582
<INTEREST-INCOME>                     355,898
<OTHER-INCOME>                              0
<EXPENSES-NET>                      3,475,826
<NET-INVESTMENT-INCOME>             7,600,654
<REALIZED-GAINS-CURRENT>           19,527,337
<APPREC-INCREASE-CURRENT>          15,859,344
<NET-CHANGE-FROM-OPS>              42,987,335
<EQUALIZATION>                              0
<DISTRIBUTIONS-OF-INCOME>           6,775,481
<DISTRIBUTIONS-OF-GAINS>           12,244,351
<DISTRIBUTIONS-OTHER>                       0
<NUMBER-OF-SHARES-SOLD>             1,758,687
<NUMBER-OF-SHARES-REDEEMED>         3,512,603
<SHARES-REINVESTED>                 1,013,850
<NET-CHANGE-IN-ASSETS>              9,630,901
<ACCUMULATED-NII-PRIOR>             6,775,481
<ACCUMULATED-GAINS-PRIOR>          12,177,099
<OVERDISTRIB-NII-PRIOR>                     0
<OVERDIST-NET-GAINS-PRIOR>                  0
<GROSS-ADVISORY-FEES>               3,403,839
<INTEREST-EXPENSE>                          0
<GROSS-EXPENSE>                     3,475,826
<AVERAGE-NET-ASSETS>              520,724,517
<PER-SHARE-NAV-BEGIN>                  19.830
<PER-SHARE-NII>                         0.300
<PER-SHARE-GAIN-APPREC>                 1.340
<PER-SHARE-DIVIDEND>                    0.260
<PER-SHARE-DISTRIBUTIONS>               0.470
<RETURNS-OF-CAPITAL>                    0.000
<PER-SHARE-NAV-END>                    20.740
<EXPENSE-RATIO>                          0.66



</TABLE>
Exhibit 32.1



CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002



I, R. Andrew Eckert, certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of SumTotal Systems, Inc. on Form 10-Q for the three-months ended March 31, 2005 fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ R. ANDREW ECKERTR. Andrew EckertPresident, Chief Executive Officer and DirectorDate: August 1, 2005




I, Neil J.
Laird, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of SumTotal Systems, Inc. on Form 10-Q for the three-months ended March 31, 2005 fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ NEIL J. LAIRDNeil J. LairdSenior Vice President and Chief Financial OfficerDate: August 1, 2005
Exhibit
32.1








CERTIFICATION PURSUANT
TO


18 U.S.C. SECTION
1350,


AS ADOPTED PURSUANT
TO


SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2004








In connection with the Quarterly Report
of Green Energy Holding Corp. (the "Company") on Form 10-QSB/A, amendment number
1 as filed with the Securities and Exchange Commission on the date hereof
(the "Report'), I, Dennis C. Murphy, Chief Executive Officer of the Company,
certify, pursuant to 18 USC ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2004, that to the best of my knowledge and
belief:





(1)
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.








/s/ Dennis C.
Murphy


Dennis
C. Murphy, Chief Executive Officer


Dated:
May 13, 2008